Evidence map›Paper›PMID 35539273›Full record

ArticleRSC advances2018

Design, synthesis and biological evaluation of

Xin You, Daqian Zhu, Wenhua Lu, Yichen Sun, Shuang Qiao, Bingling Luo, Yongliang Du, Rongbiao Pi, Yumin Hu, Peng Huang and 1 more

Abstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Synthesis ofBeilstein journal of organic chemistry · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xin YouSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Daqian ZhuSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Wenhua LuSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Yichen SunSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Shuang QiaoSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Bingling LuoSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Yongliang DuSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Rongbiao PiSchool of Pharmaceutical Sciences, Sun Yat-sen University 132 Waihuan East Road Guangzhou 510006 China.
Yumin HuSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Peng HuangSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.
Shijun WenSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University 651 Dongfeng East Road Guangzhou 510060 China wenshj@sysucc.org.cn huangpeng@sysucc.org.cn.ORCID https://orcid.org/0000-0002-9347-8243

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a set of structurally diverse synthetic carbazoles was screened for their anticancer activities. According to structure-activity relationship studies, carbazoles with an

Identifiers

PMID35539273
PMCPMC9080423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.